TdC 325: Clinicagens de diálise - Parte 1

·38 min·2 clips

Two nephrologists join to demystify when to start hemodialysis, starting with urgent indications like the AEIOU mnemonic.

1. Ta de Clinicagem hosts Aline Campos, Caio Bastos, and Jonatas Zanovelli present the first of a two-part series on hemodialysis from the internist's perspective. 2. Caio Bastos and Jonatas Zanovelli are both nephrologists; this is an explicit clinician-to-clinician teaching format with Aline serving as the non-specialist moderator. 3. The episode's core thesis is equipping internists with practical frameworks for when to initiate dialysis, which modality to choose, and how to manage vascular access in both acute and chronic settings. 4. The AEIOU mnemonic (Acidosis, Electrolytes/hyperkalemia, Intoxication, Overload, Uremia) covers the emergency dialysis indications but the hosts note that bedside application is far more nuanced than a mnemonic suggests. 5. The demand-capacity mismatch framework is introduced to explain refractory hypervolemia: dialysis is indicated not when urine output falls to zero, but when renal output — despite maximal diuretics — cannot keep pace with fluid intake, with cumulative positive fluid balance independently linked to higher ICU mortality. 6. For hyperkalemia, KDIGO guidelines cite a serum potassium above 6 mEq/L (or above 6.5 with ECG changes) as a threshold, but the hosts emphasize that context matters: hyperkalemia from an easily reversible cause (ACE inhibitor discontinuation) is managed differently than hyperkalemia in AKI stage 3 with ongoing sepsis. 7. Treatments discussed before dialysis for hyperkalemia include insulin-glucose infusion, salbutamol, sodium bicarbonate in acidotic patients, furosemide, and patiromer/sodium zirconium cyclosilicate (lokelma). 8. For metabolic acidosis, the Bicar-ICU-2 trial used up to approximately 500 mL of 8.4% sodium bicarbonate over 24 hours; the hosts note that if the patient is already developing hypernatremia or worsening hypervolemia from bicarbonate, dialysis indication emerges. 9. Uremic encephalopathy (characterized by asterixis/flapping) and uremic pericarditis (unexplained pericardial effusion) are the two main acute uremia indications; no absolute urea cutoff exists, but AKIKI-2 treated urea >300 as an extreme late endpoint associated with worse outcomes. 10. Other dialysis indications mentioned include toxic alcohol poisoning (methanol, ethylene glycol), salicylate toxicity, metformin-associated lactic acidosis, hyperammonemia in hepatic encephalopathy, and CO2 removal in severe ARDS. 11. Four major RCTs of early versus late dialysis timing in AKI (AKIKI, IDEAL, START, AKIKI-2) found no mortality difference, because a substantial proportion of 'late' group patients recovered renal function spontaneously, avoiding dialysis entirely. 12. AKIKI-2 extended the late endpoint to urea >300 and found that this ultra-late strategy was significantly worse, establishing the 'late but not too late' principle. 13. The SCAMP score (a decision flowchart for dialysis initiation) outperformed nephrologist clinical judgment in one study: in 57% of cases where the tool indicated dialysis, the nephrologist chose to wait — and of those, 33% eventually required dialysis anyway. 14. The furosemide stress test (1 mg/kg for diuretic-naive patients, 1.5 mg/kg for prior furosemide users, with a positive result defined as <200 mL urine output in 2 hours) predicts progression to AKI stage 3 or dialysis need, but is only valid before dialysis is initiated. 15. In chronic kidney disease, no specific GFR threshold mandates dialysis initiation; symptoms — particularly uremic anorexia, weight loss, and encephalopathy — guide timing, typically appearing around GFR 10–15 mL/min. 16. The KFRE (Kidney Failure Risk Equation) calculator estimates 2- and 5-year risk of dialysis need; patients with >40% risk within 2 years should be referred for AV fistula creation, transplant evaluation, or peritoneal dialysis planning. 17. Hemodialysis modalities are classified by duration: conventional (up to 6 hours, high efficiency), prolonged (6–12 hours), and continuous (>12 hours, typically >24 hours); continuous is preferred for neurocritical patients and hemodynamically unstable patients requiring large ultrafiltration volumes. 18. Of Brazil's 172,585 patients on dialysis as of the 2024 census, 5.6% use peritoneal dialysis; the hosts note this proportion is expected to grow. 19. Nephrologists, ICU nurses, and internal medicine residents working in ICU or general wards with dialysis-dependent patients will get the most practical value. 20. Non-clinicians and listeners without nephrology background will find the episode too technical, as it assumes familiarity with AKI staging, renal replacement terminology, and trial acronyms.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Ta de Clinicagem